Erratum to: Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage. (Int J Cancer, 2016, 138, 6, (1350-60) 10.1002/ijc.29875);Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage

International Journal of Cancer

Volumn 138, Issue 6, 2016, Pages 1350-1360

  Nilssen, Yngvar ^a   Strand, Trond Eirik ^a   Fjellbirkeland, Lars ^b,c   Bartnes, Kristian ^d,e   Brustugun, Odd Terje ^f   O'Connell, Dianne L ^g,h   Yu, Xue Qin ^g,h   Møller, Bjørn ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e UNIVERSITY OF TROMSØ   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g CANCER RESEARCH DIVISION   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

lung cancer; national population based; radiotherapy; surgery

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER STATISTICS; CANCER SURGERY; CANCER THERAPY; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEALTH INSURANCE; HISTOPATHOLOGY; HUMAN; INCOME; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORWAY; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; SYMPTOM; VERY ELDERLY; INSURANCE; LUNG NEOPLASMS; METASTASIS; MULTIMODALITY CANCER THERAPY; ODDS RATIO; REGISTER; SOCIOECONOMICS;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NORWAY; ODDS RATIO; REGISTRIES; SOCIOECONOMIC FACTORS; UNIVERSAL COVERAGE;

EID: 84954384658     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30113     Document Type: Erratum

References (38)

1. The Norwegian Directorate of Health. [Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfolgning av lungekreft]. Oslo. 2014.
2. Zhang B, Zhu F, Ma X, et al., Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol 2014; 112: 250-5.
3. Solda F, Lodge M, Ashley S, et al., Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol. 2013; 109: 1-7.
4. Forrest LF, Adams J, Wareham H, et al., Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med 2013; 10: e1001376.
5. Currow DC, You H, Aranda S, et al., What factors are predictive of surgical resection and survival from localised non-small cell lung cancer? Med J Aust 2014; 201: 475-80.
6. Forrest LF, White M, Rubin G, et al., The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study. Br J Cancer 2014; 111: 608-18.
7. Riaz SP, Luchtenborg M, Jack RH, et al., Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer 2012; 48: 54-60.
8. Strand TE, Bartnes K, Rostad H., National trends in lung cancer surgery. Eur J Cardiothorac Surg 2012; 42: 355-8.
9. Berglund A, Lambe M, Luchtenborg M, et al., Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open 2012; 2.
10. Myrdal G, Lamberg K, Lambe M, et al., Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden). Lung Cancer 2009; 63: 16-22.
11. Johnson AM, Hines RB, Johnson JA, III, et al. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer 2014; 83: 401-7.
12. Larsen IK, Smastuen M, Johannesen TB, et al., Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45: 1218-31.
13. Parkin DM, Whelan SL, Ferlay J, et al., Cancer Indidence in Five Continents, vol. VIII. Lyon: International Agency for Research on Cancer, 2002. 782 p.
14. U.S. Department of Health and Human Services. SEER program: comparative staging guide for cancer. U.S. Department of Health and Human Services, Bethesda, MD, 1993.
15. Asli LM, Kvaloy SO, Jetne V, et al., Utilization of radiation therapy in Norway after the implementation of the national cancer plan-a national, population-based study. Int J Radiat Oncol Biol Phys 2014; 90: 707-14.
16. National Quality Register for Lung Cancer. [Aarsrapport 2014]. Oslo: Cancer Registry of Norway, 2014.
17. Charlson ME, Pompei P, Ales KL, et al., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
18. Nilssen Y, Strand TE, Wiik R, et al., Utilizing national patient-register data to control for comorbidity in prognostic studies. Clin Epidemiol 2014; 6: 395-404.
19. StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.
20. White IR, Royston P, Wood AM., Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011; 30: 377-99.
21. Fine JP, Gray RJ., A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc 1999; 94: 496-509.
22. Berglund A, Holmberg L, Tishelman C, et al., Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax 2010; 65: 327-33.
23. Tal om tobakk 1973-2012 [database on the Internet]. Available at: https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/319/Tal-om-tobakk-1973-2012-IS-2064.pdf. Accessed on July 2, 2015.
24. Galobardes B, Shaw M, Lawlor DA, et al., Indicators of socioeconomic position (part 1). J Epidemiol Commun Health 2006; 60: 7-12.
25. Dalton SO, Steding-Jessen M, Jakobsen E, et al., Socioeconomic position and survival after lung cancer: influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010. Acta Oncol 2015; 54: 797-804.
26. Wouters MW, Siesling S, Jansen-Landheer ML, et al., Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol 2010; 36: S83-92.
27. Sant M, Minicozzi P, Allemani C, et al., Regional inequalities in cancer care persist in Italy and can influence survival. Cancer Epidemiol 2012; 36: 541-7.
28. Crawford SM, Sauerzapf V, Haynes R, et al., Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009; 101: 897-901.
29. Strand TE, Brunsvig PF, Johannessen DC, et al., Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival. Int J Radiat Oncol Biol Phys 2011; 80: 133-41.
30. Kaergaard Starr L, Osler M, Steding-Jessen M, et al., Socioeconomic position and surgery for early-stage non-small-cell lung cancer: a population-based study in Denmark. Lung Cancer 2013; 79: 262-9.
31. Rich AL, Tata LJ, Free CM, et al., Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011; 66: 1078-84.
32. Sitas F, Weber MF, Egger S, et al., Smoking cessation after cancer. J Clin Oncol 2014; 32: 3593-5.
33. Tyldesley S, Zhang-Salomons J, Groome PA, et al., Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 2000; 47: 469-80.
34. Chen AB, Cronin A, Weeks JC, et al., Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol 2013; 31: 558-64.
35. Hayman JA, Abrahamse PH, Lakhani I, et al., Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007; 69: 1001-7.
36. Wong J, Xu B, Yeung HN, et al., Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys 2014; 90: 224-30.
37. Murphy JD, Nelson LM, Chang DT, et al., Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract 2013; 9: e220-7.
38. GINI Index. Available at: http://data.worldbank.org/indicator/SI.POV.GINI /. Accessed 7 Oct 2015.